期刊文献+

肾功能不全对心力衰竭患者NT-proBNP影响的初步研究 被引量:5

Impact of renal insufficiency on the level of NT-pro BNP in patients with heart failure: a pilot study
原文传递
导出
摘要 目的氨基末端脑钠肽前体(NT-pro BNP)是诊断心力衰竭的有力标记物。本文旨在研究肾功能不全(血肌酐(Cr)>133μmol/L)的情况下,慢性心力衰竭患者血浆NT-pro BNP水平的变化,并初步探讨Cr>133μmol/L时NT-pro BNP诊断心力衰竭的截断值。方法研究对象为43例慢性心力衰竭患者(其中20例合并肾功能不全未行血液透析治疗)和115例心功能正常患者(其中39例合并肾功能不全),测定其血浆NT-pro BNP和血肌酐浓度。结果无论正常组还是心衰组中,肾功能不全患者的NT-pro BNP浓度明显高于相应的肾功能正常患者水平,差异有统计学意义(P<0.05)。NT-pro BNP的截断值2 200 ng/L时诊断心力衰竭伴肾功能损害具有较好的敏感性(0.795)和特异性(0.797)。结论NT-pro BNP检测结果明显受到肾功能的影响,当心力衰竭患者合并肾功不全时NT-pro BNP相对升高,相应的提高其截断值可以有效提高心力衰竭诊断的特异性。 Objective N-terminal pro B-type natriuretic peptide (NT-proBNP) is one of thewell-established markers for heart failure. We attempt to assess the impact of renal insufficiency on the level of NT-proBNP in patients with heart failure and discuss the appropriate cut-off value when the serum creatinine (Cr)〉133 μmol/L. Methods 43 chronic heart failure patients (of which 20 are combined with renal insufficiency) and 119 controls with normal heart function (of which 39 are with renal insufficiency) were included in the study.The plasma NT-proBNP and serum Cr were measured. Results In both normal (Nor) and heart failure (HF) groups, NT-proBNP concentrations were higher in patients with renal insufficiency than those of patients without renal insufficiency. There was a statistically significant difference between the two sets(with or without renal insufficiency,P〈0.05). The cut-off value of 2 200 ng/L NT-proBNP, for the diagnosis of heart failure combined renal insufficiency, has appropriate sensitivity (0.795) and specificity (0.797). Conclusion The plasma level of NT-proBNP was obviously impacted by the kidney function. The NT-preBNP level was relatively elevated in patients with deeompensated renal insufficiency. A higher cut-off value is needed to gain better specificity during clinical diagnosis of heart failure with renal insufficiency.
出处 《热带医学杂志》 CAS 2015年第2期224-226,共3页 Journal of Tropical Medicine
关键词 心力衰竭 血肌酐 肾功能不全 NT-pro BNP heart failure serum ereatinine renal insufficiency NT-proBNP
  • 相关文献

参考文献7

  • 1Sears SF, Woodrow L, Cutitta K, et al. A patient's guide to living confidently with chronic heart failure [J]. Circulation, 2013, 127 ( 13 ) : e525-528.
  • 2Januzzi JL, van KR, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study [J]. Eur Heart J, 2006, 27(3):330-337.
  • 3Januzzi JL, Troughton R. Are serial BNP measurements useful in heart failure management serial natriuretic peptide measurements are useful in heart failure management [J]. Circulation, 2013, 127(4) :500-507.
  • 4Palazzuoli A, peptides (BNP in heart failure Gallotta M, Quatrini I, et al. Natriuretic and NT-proBNP): measurement and relevance [J]. Vasc Health Risk Manag, 2010, 6:411- 418.
  • 5Vickery S, Price CP, John RI, et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventficular hypertrophy [J]. Am J Kidney Dis, 2005, 46(4):610-620.
  • 6Palladini G, Foli A, Milani P, et 81. Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure [J]. Am J Hematol, 2012, 87(5) :465-471.
  • 7Pimenta J, Sampaio F, Martins P, et al. Aminoterminal B- type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications[J]? Nephron Clin Pract, 2009, 111 (3) : c182-c188.

同被引文献31

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部